BOSTON, Sept. 18, 2023 (GLOBE NEWSWIRE) -- LAPIX Therapeutics, Inc. (“LAPIX”), a biopharmaceutical company focused on developing novel, orally bioavailable…
Jonathan Kennedy, Chief Financial Officer, Route 92 Medical Jonathan Kennedy has just joined Route 92 Medical as Chief Financial Officer.…
One of the Nation’s Largest Infusion Pharmacy Networks Selects Inovalon’s Leading Cloud Native Solution, ScriptMed® Infusion, to Advance Patient-Centric Care…
Believes Court Erred by Ignoring Settled New York Law and Decades of Precedent Company is Exploring All Options in Response…
Includes dedicated version for integration with Ponemah data management software from Data Sciences International (DSI) Expands reach of unique, non-invasive…
AI-powered target discovery for a bacterial pathogen with a high medical need where no vaccine is currently available Evaxion’s proprietary AI-platforms…
CORAL GABLES, Fla., Sept. 18, 2023 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. ("Catalyst") (Nasdaq: CPRX), a commercial-stage biopharmaceutical company focused…
– AB126, an unmodified exosome derived from neural stem cells, shows native therapeutic activity with anti-inflammatory and neuroprotective properties through modulation…
Findings from annual study also reinforce the value of whole-person care, equitable access and a balanced approach to GLP-1s &…
- Topline results from this study are expected in early Q1 2024 - Celltrion has a right of first negotiation…